Copy
See below for a daily digest of the latest Huntington's Disease news!

Promising Huntington’s Therapy Candidate Discussed at Hereditary Disease Foundation Meeting

Aug 12, 2016 07:00 am | Magdalena Kegel

 

Hereditary Disease Foundation discusses IONIS-HTTAbout 300 international scientists and industry leaders recently gathered in Cambridge, Massachusetts, for the Hereditary Disease Foundation‘s 10th biennial “Milton Wexler Celebration of Life” Symposium, to promote collaborations that can take scientific findings from the laboratory into the lives of patients as treatments. One of the highlights of the meeting, according to the foundation, was a […]

The post Promising Huntington’s Therapy Candidate Discussed at Hereditary Disease Foundation Meeting appeared first on Huntington's Disease News.

Read More
share on Twitter Like Promising Huntington’s Therapy Candidate Discussed at Hereditary Disease Foundation Meeting on Facebook

Prana’s PBT2 Shown to Lower Tau Protein in Neurodegeneration Cell Model

Aug 10, 2016 07:00 am | Magdalena Kegel

 

Prana Biotechnology’s experimental drug PBT2 lower tau aggregates in three-dimensional cell model of neurodegeneration.In recent years, Huntington’s disease has joined the group of neurodegenerative diseases characterized by aggregation of the tau protein in fibrillary tangles inside neurons. An invention by Prana Biotechnology might give new insights into the disease processes and allow for new drug candidates to be screened for activity against the disease. The tool, originally aimed at Alzheimer’s […]

The post Prana’s PBT2 Shown to Lower Tau Protein in Neurodegeneration Cell Model appeared first on Huntington's Disease News.

Read More
share on Twitter Like Prana’s PBT2 Shown to Lower Tau Protein in Neurodegeneration Cell Model on Facebook

Recent Posts

Protein Identified That Protects Cells from Neurodegenerative Diseases, Possibly Leading to New Therapies
Protein’s Misconduct in Mitochondria May Be Cause of Nerve Cell Death in Huntington’s
Vaccinex’s VX15 Antibody for Huntington’s Fast Tracked by FDA
Huntington’s Drug Candidate Huntexil Can Trigger Neuroprotection
Link Between Low Cysteine and Huntington’s Disease Revealed in Mouse Study

Copyright © 2016 BioNews Inc., All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences